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ABSTRACT 
 
This thesis entitled “Total synthesis of (+)-valienamine, (+)-4-epi-valienamine, (-)-
Synrotolide diacetate, attempted synthesis of (+)-modiolide-A and Synthesis of 
GABA receptor agonists, azasugars and C-glycosides via Baylis-Hillman reaction” 
divided into three chapters  
 
Chapter I: Stereoselective total synthesis of (+)-valienamine and (+)-4-epi- 
valienamine 
This chapter dealt with stereoselective total synthesis of (+)-valienamine and (+)-4-epi- 
valienamine 
Carbaglycosylamines (aminocyclitols), such as valienamine, validamine, 
valiolamine were first isolated as the components of the validamycin and its analogs 
having enzyme inhibitory activity against many glycosidases. 
                                                                                                                                                                                                                                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glycosidases are the enzymes that cleave the glycosidic bonds and are responsible 
for the glycoprotein processing and carbohydrate digestion in animals. Hence, inhibition 
of these enzymes has significant implications in both antiviral and diabetic 
chemotherapy.1 Valienamine [(1S,2S,3S,4R)-1-amino-5-(hydroxymethyl)cyclohex-5-ene-
2,3,4-triol] (Figure 1), a carbasugar, was first isolated from microbial degradation of 
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validoxylamine A with Pseudomonas denitrificans2  or Flavabacterium saccharophilum3  
or from the NBS cleavage of validoxylamine A and its derivatives.4 Valienamine is a 
core unit of many pseudo-oligosaccharides and pseudo-amino sugars such as 
validamycins, acarbose, amylostatins, adiposins, acarviosin, and trestatins.5a Valienamine 
shows strong α-glycosidase inhibitory activity against various hydrolases6 inhibiting 50% 
activity of maltase and sucrase at concentrations of 3.4 × 10-4 and 5.3 × 10-5 M and 
antibiotic activity against Bacillus species.7 Due to its varied and important biological 
activities, several syntheses5 were reported in an effort to arrive at more potent modified 
analogs.  
Ever since the pioneering work of Paulsen8 et al and others,9 elegant syntheses of 
valienamine were reported.5 While, most of them used D-glucose or its derivatives10,11a.c 
as the chiral starting material and built the carbocyclic framework using various key 
reactions, the most interesting to us was the use of ring-closing alkene metathesis 
protocol.11 Owing to our broad interest in applying metathesis based synthetic routes to 
access bioactive natural products,12 herein we report the stereoselective total synthesis of 
valienamine 1 and the first synthesis of 4-epi-valienamine 2 wherein ring-closing enyne 
metathesis (RCEYM) is employed as the key step for constructing the carbocyclic ring 
system. We envisioned that the ensuing vinylic double bond would serve as a masked 
‘hydroxymethyl side chain’ as well as a handle for designing NCEs.13 
Thus, the synthesis (Scheme 1) began following the literature procedure. The 
known14 compound 3, obtained from L-serine, on Sharpless asymmetric dihydroxylation 
(AD-mix-α/OsO4/MeSO2NH2/tBuOH: H2O/0˚ C) provided a separable mixture of 
diastereomers in 99:1 ratio. Diol 4 was protected as its MOM-ether 5 
(MOMCl/DIPEA/CH2Cl2/rt, 93%). Next, reduction of 5 with LiAlH4 in THF gave the 
primary alcohol 6 (75%). Alcohol 6 on Swern oxidation and quenching the ensuing 
aldehyde with TMS-acetylenic anion (TMS-acetylene/n-BuLi/THF/-78 ˚C) afforded 
propargylic alcohol which upon TMS deprotection (K2CO3/MeOH) furnished 7 and 7a 
(70% overall yield for three steps) as inseparable diastereomeric mixture (8.0:2.0, anti:syn). 
The ratio of diastereomers was determined by the 1H NMR analysis wherein the relative 
integration of the separable methoxy protons of the MOM-groups. Herein, the predominant 
1,2-anti selectivity maybe explained due to non-chelation addition protocol. In order to 
                                                                                                                                  Abstract 
 3 
alter the stereoisomer in favor of the desired stereochemistry, various strategies were tried. 
Firstly, additives such as ZnCl2, ZnBr2 and MgBr2.Et2O were tried to augment the chelation 
controlled addition as the means of enhancing the syn selectivity, but the observed des were 
5%, 16% and 32% respectively. Later, the diastereomeric mixture 7 and 7a was subjected 
 
 
 
 
 
 
 
 
 
 
to a Mitsunobu reaction (p-NO2C6H4COOH/DIAD/TPP/THF/rt) followed by 
methanolysis (K2CO3/MeOH/rt) to provide the desired diastereomer as the major product 
(8:2 ratio respectively). However, practical separation of 7 and 7a diastereomeric mixture 
into individual entities was possible after derivatization (MOMCl/DIPEA/CH2Cl2/0 ˚C/rt) 
as MOM-ethers 8 and 8a.  
In order to enhance the diastereoselectivity in favor of the desired stereoisomer, Carreira 
asymmetric alkynylation reaction15 {(-)-N-methylephedrine/Zn(OTf)2/Et3N/TMS-
acetylene/touene/rt} was conducted on the corresponding aldehyde to furnish propargyl 
alcohol 7a in higher yield (86%) and selectivity (98% de). Likewise, Carreira 
alkynylation reaction using (+)-N-methylephedrine as the chiral ligand under similar 
reaction conditions gave 7 in equal optical and chemical yield. The absolute 
stereochemistry of the newly created stereogenic center of 7 was assigned as S based on 
the literature precedence15,16 and that of 7a as R. Next, the secondary hydroxyl group in 
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Scheme 1. Reagents and conditions: (a) (i) AD-mix-α, OsO4, MeSO2NH2, tBuOH:H2O, 0 oC, 16 h, 84%; (b) DIPEA, MOMCl,
CH2Cl2, 0 oC-rt, 17 h, 93%; (c) LiAlH4, THF, 0 oC-rt, 1 h, 75%; (d) (i) COCl2, DMSO, Et3N, -78 oC; (ii) (x) TMS-acetylene,  n-
BuLi, -78 oC, 4 h; (y) Zn(OTf)2,  (-)-N-methylephedrine, Et3N, toluene, 86%; (z) Zn(OTf)2, (+)-N-methylephedrine, Et3N,
toluene, 80%; (iii) K2CO3, MeOH, 0 oC, 1 h.; (e) (i) p-NO2-C6H4COOH, DIAD, TPP, THF, 0 oC-rt, 1.5 h; (ii) K2CO3, MeOH, 0
oC (84% over two steps); (f) DIPEA, MOMCl, CH2Cl2, 0 oC-rt, 8 h.
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7a was protected as its MOM-ether (MOMCl/DIPEA/CH2Cl2/0 ˚C/rt) to afford 8 (90%). 
The thus obtained diastereomer 8 was taken up for further use.  
Further, the independently accessed 8 and 8a were correlated with those obtained earlier 
and found to have identical spectral data. To continue the synthesis, 8 on selective 
cleavage of acetonide group using CuCl2.2H2O in acetonitrile at 0 oC temperature gave 
the free primary alcohol 9 (92%). Swern oxidation of 9 followed by Wittig olefination 
(CH3+PPh3I-/KOtBu/THF/0 oC) furnished enyne 10 (64%). Compound 10 was 
characterized by its spectral data, wherein it’s 1H NMR spectrum revealed the 
characteristic acetylenic proton at δ 2.46 ppm as a doublet (J = 1.8 Hz) and the olefinic 
protons as multiplets at δ 6.01 and at δ 5.34-5.20 ppm. The IR spectrum displayed the 
characteristic C-H and C-C stretching frequencies at 3252 and 2154 cm-1 respectively. 
The critical ring-closing enyne metathesis reaction17a of 10 was conducted with Grubbs’ 
catalyst (A, 10 mol%/solvent/reflux/12 h) under two different solvents systems in CH2Cl2 
and in toluene independently. Both the reactions offered the desired product 11, albeit in 
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Scheme 2.  reagents and conditions; (a) CuCl2. 2H2O, CH3CN, 0 oC, 0.5 h, 92% (b)  (i) COCl2, DMSO, Et3N, -78o C; 
(ii) CH3 +PPh3I-, KOtBu, THF, 0 oC, 8 h, 64%; (c) Grubbs' 2nd generation catalyst (A, 10 mol%), ethylene
atmosphere, toluene, 110 oC, 8 h, 92%; (d) OsO4, NMO (0.05 eq.), acetone-water (4:1), 5 h, (ii) NaIO4, MeOH:H2O
(9:1), 0 oC, 1 h, (iii) NaBH4, MeOH, 0 oC, 5 min (62% over three steps), (e) TFA, CH2Cl2, 0 oC, 4 h, (ii) Ac2O,
pyridine, DMAP, rt,14 h, (70% over two steps).
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Low yields. Gratifyingly, the same reaction in toluene (110 ˚C) under ethylene 
atmosphere17b furnished vinylcyclohexene derivative 11 in high yield (92%). Compound 
11 was identified from its spectral data. The 1H NMR spectrum of 11 indicated the 
absence of the acetylenic and terminal olefinic protons whilst displaying the 
characteristic olefinic protons at δ 6.24 ppm as a double doublet (J = 10.9, 17.3 Hz), at δ 
5.78 ppm as a double doublet (J = 3.0, 15.8 Hz), at δ 5.44 as a doublet (J = 16.9 Hz) and 
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at δ 5.10 ppm as a doublet (J = 10.9 Hz). The mass spectrum had an M+H peak at m/z of 
404 in support of the assigned structure.  
With the vinylcyclohexene derivative 11 in hand, the next task was the selective 
transformation of the vinylic double bond into a hydroxymethyl side chain. The 
conversion was planned via a sequential dihydroxylation-oxidative cleavage-reduction 
protocol. For example, selective dihydroxylation of the vinylic olefin 11 
(OsO4/NMO/acetone:H2O) and the oxidative cleavage of the ensuing diol 
(NaIO4/MeOH:H2O/rt) gave the corresponding aldehyde which was reduced 
(NaBH4/MeOH/0 ºC) to afford the carbocyclic methanol 12 (62% overall yield for three 
steps) without any purification of the intermediates. Global deprotection of MOM and 
Boc protecting groups with TFA in CH2Cl2 at room temperature afforded valienamine 1 
which on acetylation (Ac2O/pyridine/DMAP/CH2Cl2/rt/16 h) furnished the pentaacetate 
derivative 13 (70% overall yield for two steps) to facilitate its easy isolation and 
characterization. The physical and spectroscopic data of 13, mp 94 ºC, [α]25 D +22.7 (c 
0.62, CHCl3) were identical to the reported values {lit.11b mp 91.5-93 ºC; [α]D +21.1 (c 
0.9, CHCl3) and lit.9a mp 92-94 ºC; [α]20 D  +20.1 (c 0.8, CHCl3)}. 
In a related approach (Scheme 3), 8a was used as the starting material and subjected to 
the same set of transformations (Scheme 2), a non-natural 4-epi-valienamine 2 (Figure 1) 
was obtained as the product. Compound 2 was thoroughly characterized18 as its 
pentacetate derivative 13a (68% overall yield for two steps). Interestingly, aminocyclitol 
2 (Figure 1) might be considered as a potential α-galactosidase inhibitor.  
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Scheme 3 reagents and conditions; (a) CuCl2. 2H2O, CH3CN, 0 oC, 0.5 h, 89%; (b)  (i) COCl2, DMSO, Et3N, -78 oC; (ii) CH3+PPh3I-, 
KOtBu, THF, 0 oC, 8 h, 61%; (c) Grubbs 2nd generation catalyst {A (Scheme 1), 10 mol%}, ethylene atmosphere,  toluene, 110 oC, 
8 h, 95%; (d) OsO4, NMO (0.05 eq.), acetone-water (4:1), 5 h, (ii) NaIO4, MeOH:H2O (9:1), 0 oC, 1 h, (iii) NaBH4, MeOH, 0 oC, 5 min 
(70% over three steps), (e) (i) TFA, CH2Cl2,  0 oC, 4 h, (ii) Ac2O, pyridine, DMAP, rt, 14 h, (68% over two steps).
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Inconclusion, a stereoselective total synthesis of (+)-valienamine and (+)-4-epi-
valienamine, a hitherto unreported diastereomer has been accomplished by the ring-
closing enyne metathesis approach to access the carbocyclic framework possessing a 
vinylic olefin which was selectively transformed into a hydroxymethyl group. 
Interestingly a closer derivative N-Octyl-4-epi-β-valienamine (NOEV)19 was found useful 
in molecular therapy for certain patients with β-galactosidosis and other lysosomal 
storage associated diseases involving CNS. 
 
Chapter II: Stereoselective total synthesis of (-)-synrotolide diacetate and attempted 
synthesis of (+)-modiolide-A  
Section A: Stereoselective synthesis of (-)-synrotolide diacetate from D-ribose 
This section dealt with the stereoselectve total synthesis of (-)-synrotolide diacetate from 
D-ribose 
 
Naturally occurring α,β-unsaturated lactones show varied pharmacological 
properties, while some exhibit antitumor activity, others posses interesting properties14.   
notable among them contain a polyoxygenated chain connected with α,β-unsaturated 
lactone moiety having antimicrobial activity, antifungal or cytotoxicity against human 
tumor cells.15a,b (-)-Synrotolide 2,15c an α-pyrone containing natural product was isolated 
from Syncolostemon rotundifolius, Continuing our interest in the synthesis of lactone 
skeleton containing bioactive natural products,8 herein we report the stereoselective total 
synthesis of synrotolide as its diacetate (1) from D-ribose through a chiron approach.  
 
 
 
 
 
 
The reported strategy derives stereocenters at C(2), C(3) and C(4) from D-ribose 
translating as those of C(10), C(9) and C(8) of 2, respectively. Additionally, chiral center  
at C(11) was generated by a diastereoselective Grignard reaction, and the one at C(5) by 
an asymmetric allylation reaction. Finally, the α-pyrone moiety was built from the 
corresponding bis-olefin by the Grubbs’ catalyst assisted RCM protocol. 
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Thus, the synthesis (Scheme 1) began following the literature procedure. The 
known16 5-O-(tert-butyldimethylsilyl)-2,3-O-isopropylidene-D-ribofuranose 3, obtained 
from D-ribose, on exposure to MeMgI in ether, resulted in a 9:1 separable diastereomeric 
mixture via a chelation controlled mode in favor of the desired diol 4 as the major 
product (85%).17 Later, both the hydroxyl groups in 4 were protected as PMB ethers 
(PMBBr/NaH/THF/rt) to furnish 5 (74%). Compound 5, on TBDMS deprotection 
(TBAF/THF/rt), afforded 6 (92%) with a free primary alcohol, which was oxidized to an  
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Scheme 1. Reagents and conditions: (a) MeMgI, Ether, -78 oC, 6 h, (76%); (b) PMBBr, NaH, THF, 0 oC-rt, 10 h, (74%) (c)
TBAF, THF, rt, 14 h, (92%); (d) (i) (COCl)2, DMSO, Et3N, CH2Cl2, -78 oC, 1h, (90%); (ii) (F3CCH2O)2POCH2COOMe,
KHMDS, 18-crown-6, THF, -78 oC,4 h, (88%); (e) DIBAL-H, Ether, 0 oC-rt, 6h, (92%); (f) (i) (COCl)2, DMSO, Et3N, CH2Cl2,
-78 oC, 1 h, (80%); (ii) I, allyltributyltin, CH2Cl2, 0 oC, 36 h,  (70%); (g) CH2=CH-COCl, DIPEA, CH2Cl2, 0 oC-rt, 10 h,  (90%); 
(h) 10% PhCH=RuCl2(PCy3)2, CH2Cl2, reflux, 8 h, (85%); (i) AlCl3, EtSH, CH2Cl2, rt, 0.5 h, (70%) (j) Ac2O, Et3N, DMAP,
CH2Cl2, 0 oC-rt, (90%); (k) CuCl2.2H2O, MeCN, rt, 5 h, (88%); (l) (i) CuCl2.2H2O, MeCN, rt, 5 h (ii) Ac2O, pyridine, rt, 12 h
(66% over two steps).
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aldehyde under Swern reaction conditions and subjected to a Wittig olefination reaction18 
[(F3CCH2O)2POCH2COOMe/KHMDS/18-crown-6/THF/-78 oC], to afford the 
corresponding α,β-unsaturated ester 7 in 88% yield predominantly as the (Z)-isomer, as 
characterized by 1H and 13C NMR spectroscopy. The coupling constant (J = 9.05 Hz) and 
the chemical shift values (δ 6.18 and δ 6.00) of the olefinic protons confirmed the (Z)-
geometry of the olefin. With ester 7 in hand, our next task was the creation of an 
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additional chiral center that corresponds to C(5) of the target compound. Thus, 7 was 
subjected to reduction with DIBAL-H in ether to afford the allylic alcohol 8 (95%), 
which was converted to the α, β-unsaturated aldehyde under Swern reaction conditions.  
This aldehyde, without further purification, on Keck asymmetric allylation19a gave 9, 
albeit in a low yield of ~25%. However, Maruoka allylation19b afforded 9 in good yield 
(70%) as inseparable diastereomers (de 90%). Acryloylation of 9 (CH2=CH-
COCl/DIPEA/CH2Cl2/ 0 oC-rt) gave separable bis-olefin 10 as the major isomer in 90% 
yield. The newly created stereocenter was tentatively assigned as depicted in the Scheme 
1, based on literature precedence but was conclusively proved later. The RCM of 10 
using Grubbs’ catalyst20[10% PhCH=RuCl2(PCy3)2/CH2Cl2/reflux/8 h] gave the α,β-
unsaturated lactone 11 in 85% yield. With the complete skeleton in hand, wherein all the 
hydroxyl functionalities were present in their protected form, a stepwise release was 
planned.  
    Initially deprotection of PMB ethers was contemplated so that they in turn could be 
acetylated. Thus, Lewis acid21 Accordingly, 12 on acetonide deprotection 
(CuCl2.2H2O/MeCN/rt/5 h) and acetylation (Ac2O/pyridine/rt/12 h), afforded 2, mp 98-101 
oC; [α]25D -10.60 (c 0.05, CHCl3);{lit.3 mp 102-103 oC; [α]25D  -11.00 (c 0.09, CHCl3)} in 
66% yield over two steps. The physical and spectroscopic data of 2 were identical to the 
reported values of synrotolide diacetate. The synthesis of 2 also established the assigned 
stereochemistry of 9. It is interesting to note that many bio-active natural products like 
spicigerolide2a and anamarine13 are endowed with tetraacetates on their skeletons. 
 In conclusion, a stereoselective total synthesis of synrotolide diacetate was 
accomplished by a versatile strategy. A combination of diastereoselective Grignard 
reaction, preferential (Z)-Wittig olefination, asymmetric allylation and ring closing 
metathesis were effectively utilized in accomplishing the synthesis 
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Section B: Attempted synthesis of (+)-modiolide-A 
This section dealt with the attempted synthesis of modiolide A from 3- butene 1-ol and 
(R)-2, 3-O-isopropylidine glyceraldehyde  
The new 10 membered macrolide modiolide-A was first isolated 22 from the 
cultured broth of a fungus paraphaeosphaeriasp, which was isolated from a marine horse 
mussel Modiolus auriculatus. Modiolide A showed antifungal activity against 
Neurospora crassa (MIC value 33.3 µg/mL) and antibacterial activity against Micriciccus 
lutes (MIC value 16.7 µg/mL). 
The retrosynthetic analysis for 1 is depicted in Scheme 1. Compound 1 can be obtained 
from ester 2 by RCM, 2 in turn can be obtained by the Yamaguchi esterification between 
acid 3 and alcohol 4. Acid 3 can be obtained from the (R)-2, 3-O-isopropylidine 
glyceraldehyde which in turn could be realized by simple chemical transformations. 4 can 
be obtained from intermediate 6 which in turn be realized from the epoxide 17, easily 
accessible by the Jacobsen kinetic resolution protocol. The racemic epoxide was obtained 
from the 3-butene 1-ol.  
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Accordingly the synthetic efforts of 1 starts with the compound 16, epoxidation of 
compound 16 with MCPBA in CHCl3 at 0 oC afforded racemic epoxide which on 
Jacobsen kinetic resolution with (S, S)-Jacobsen catalyst provides compound 17 as chiral 
epoxide in 44% yield. Opening of epoxide 23 using trimethyl sulphonium iodide , n-BuLi 
in  dry THF at -10 oC provided secondary allylic alcohol 18 in 72% yield then the 
secondary hydroxy group in 18 protected as its MOM ether (MOMCl/ DIPEA/CH2Cl2) to 
furnish compound 19 in 80% yield. The primary TPS group in 19 was deprotected with 
(TBAF/THF/rt) to afford 20 (94%) with a free primary alcohol, which was oxidized to an 
aldehyde under Swern reaction conditions and subjected to the Grignard reaction 
(MeMgI/ether/0 oC), resulted in a inseparable diastereomeric mixture 4 in 88% yield.24 In 
order to alter the stereochemistry of the stereoisomer to the derived one oxidation of  the 
diastereomeric mixture with Dess-Martin periodinane in dry CH2Cl2 at 0 oC-rt for 4 h 
followed by the selective reduction with SmI2 in THF:MeOH afforded alcohol 5 in 66% 
over two steps (Scheme 2). 
 
 
 
 
 
To prepare acid 3, the known compound 7 prepared from D-mannitol, on 
reduction with DIBAL-H in CH2Cl2 at  0 oC afforded allylic alcohol 8, which is protected 
as its TPS ether (TPSCl/imidazole/CH2Cl2) to give 9 in 89% yield. Later, selective 
cleavage of acetonide group using CuCl2.2H2O in acetonitrile at 0 oC temperature gave 
the diol 10 in 94% yield. Later primary hydroxyl group in diol 10 was selectively 
monotosylated (TsCl/Et3N/CH2Cl2/rt) which upon treatement with K2CO3 in MeOH 
afforded epoxide 11 in 77% yield (Scheme 3). 
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Scheme 2; Reagents and conditions; (a) (i)  MCPBA, CHCl3, 0 O C_rt, 90%; (ii) (S,S)-Jacobsen catalyst, H2O, THF, rt, 15 h, 42%; 
(b) TMSI, n-BuLi, THF, -10 o C, 5h, 73%; (c) MOMCl, DIPEA, CH2Cl2, 8h, 89%; (d) TBAF, THF, 0 O C_rt, 3h, 84%; (e)  (i) 
(COCl)2, DMSO, Et3N, CH2Cl2, -78 oC, 1 h; (ii) MeMgI, ether, 0 O C, 2h, 90%; (f) (i) DMP, CH2Cl2,0 O C_rt, 1h; (ii) SmI2, 
MeOH:THF(1:1), 8h, 66%
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Scheme 2:Reagents and conditions: a) DIBAL-H, CH2Cl2, 0 oC, 6 h, 92%; (b) TPSCl, imidazole, CH2Cl2, 5 h, 86%; (c) CuCl2.
2H2O, CH3CN, 0 o C,1 h, 90%;  (d) i) TsCl, Et3N, CH2Cl2, 0 oC-rt, 12 h, 75%; ii) K2CO3, MeOH,  0 oC-rt, 2 h, 92%; (e) TMSI, n-
BuLi, THF, -10 oC, 4 h, 72%; (f) PMBBr, NaH, THF, 0 oC-rt, 6 h, 75%; (g) TBAF, THF, 0 oC-rt, 5 h, 88%; (e) i) (COCl)2,
DMSO, Et3N, CH2Cl2, -78 oC, 1 h; ii) NaClO2, NaH2PO4.2H2O, t-BuOH:2-methyl-2-butene (3:1), 0 oC-rt, 6 h, (71% for two
steps);
 
The epoxide was ring-opened as homologated allylic alcohol using trimethyl 
sulphonium iodide, n-BuLi in dry THF at -10 oC to afford di vinylic methanol. The 
secondary hydroxyl group in 12 was protected as its PMB ether (PMBBr/NaH/THF/rt) to 
furnish compound 13 in 75% yield. The primary TBDPS group in 13 was deprotected 
with (TBAF/THF/rt) to afford 14 (94%) with a free primary alcohol, which was oxidized 
to the corresponding acid by a two-step process; firstly to an aldehyde by Swern 
oxidation and then on perchlorate oxidation (NaClO2/NaH2PO4.2H2O/t-BuOH/2-methyl-
2-butene) to the acid 3 (82% over two steps). 
Having two intermediates acid 3 and alcohol 4 in our hand, next task was to couple them 
through an ester bond (Scheme 4). Towards this, acid 3 was treated with 2,4,6-
trichlorobenzoyl chloride25 and Et3N in dry THF to form a mixed anhydride and to this 
mixture alcohol moiety 4 was added to afford ester 2 in 59% yield.  
 
 
 
 
   
 
 
OPMB
O
O OMOM
O
O
PMBO
OMOM
2
3 4+
21
Scheme 4: Reagents and conditions: ( a) 2,4,6-trichlorobenzoyl chlorode, Et3N, THF, 4 h, then  4, 4h, 56%; (b) 
Grubbs II, CH2Cl2, reflux 12 h.
a b x
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To obtain macro lactone 21, the bis olefine moiety was subjected to ring-closing 
metathesis (RCM) using Grubb´s II generation catalyst in dichloromethane, provided un-
identified products. We are tried several reaction conditions by changing the solvents like 
toluene, dichloroethane with increase in the reaction timings and loading the catalyst at 
different concentrations, but in each case we did not get the desired product. 
Based on the literature26 survey on RCM for constructing 10 membered macrolides, 
wherein the two allylicalcohol systems share1, 4-syn relation ship and such an 
arrangement of the stereo centres did not allow the cyclisation. Due to the failure to 
obtain lactone through RCM protocol, alternate synthetic strategy is underway in our 
laboratory to obtain lactone under Yamaguchi lactonisation conditions. 
Chapter III: Synthesis of GABA receptor agonists, azasugars and C-glycosides via 
Baylis-Hillman reaction.  
Section A: Synthesis of chiral tetrahydropyridines as GABA receptor agonists and 
azasugars via Baylis-Hillman reaction and RCM protocol 
This section dealt with the Synthesis of chiral tetrahydropyridines as GABA potential 
receptor agonists and azasugars via Baylis-Hillman reaction and RCM protocol 
Baylis-Hillman reaction is an effective method for the C-C bond formation reaction 
that results in highly functionalized products.27 These products are useful in the synthesis of 
natural products such as polyketides and alkaloids. In the recent years we were involved in 
expanding the horizon of asymmetric Baylis-Hillman reaction28 and also elaborating the 
ensuing adducts in the synthesis of bio-active natural products. One of the most useful 
method for the construction of large and medium size heterocyclic rings is transition metal 
catalyzed ring-closing metathesis (RCM)20 particularly notable because of functional group 
tolerance, operational simplicity and ready availability of the catalyst and equally useful is 
the catalytic dihydroxylation6 reaction. Herein a Baylis-Hillman-RCM-Cis-dihydroxylation 
protocol is used to build first the core tetrahydropyridine skeleton which was later 
hydroxylated or hydrogenated to generate the additional chiral centres. 
GABA is one of the major mammalin neurotransmitters inhibitor. Many diseases 
such as schizophrenia, epilepsy, and Parkinson’s hasbeen linked to functions of GABA. 
                                                                                                                                  Abstract 
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From in vitro studies tetrahydropyridine29 moiety was identified as the pharmacophore 
for GABA inhibition. 
 
 
 
 
 
 
As a part of our continued interest in the asymmetric Baylis-Hillman reaction and C-
glycosides,34 herein we report the synthesis of multifunctional products, having α-
methylene-β-hydroxy-γ-amino acid structure derived from chiral N-Boc allyl-α-amino 
aldehydes with good diastereoselectivity. These adducts are transformed into 1,2,3,6-chiral 
tetrahydropyridine-4-carboxylates via ring-closing metathesis, which are related to 
isoguvacine. Finally these adducts are further derivatized as azasugars.30 Interestingly, all 
these compounds closely resemble monosaccharides in terms of their shape and structure 
(Figure 2).These glycosidase inhibitors are potentially useful in the treatment of cancer, 
viral infection including HIV, diabetes, lysosomal storage disorders such as Gaucher’s, 
Fabry diseases and non-insulin dependent diabetes. 
 
 
 
 
During the course of our synthesis, amino acid 4 can be transformed to Boc procted  N-
allylated aldehyde 10 using simple chemical transformations (Scheme 1). Same 
transformations applied for Natural aminoacids alanine, valine, isoleucine and 
phenylalanine results the corresponding aldehydes 11a, 11b, 11c and 11d respectively. 
         
N
H
COOH
N
H
COOH
N
H
O
N
HO
THIP
1
isonipecotic acid isoguvacine
2 3
Figure 1. Some GABA agonist receptors
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Figure 2.  Natural and synthetic azasugars as glycosidase inhibitors.
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R
OH
O
NH2
R
OMe
O
NH2 HCl
R
OTBS
NHBoc
R
BocN
OTBS
R
OMe
O
NHBoc
6
8
9
Scheme 1. Reagents and conditions: (a) AcCl, MeOH, 0 oC-rt; (b) (Boc)2O, Et3N, THF, 0 oC-rt,  8 h;  (c) LAH (1.5 
eq.), THF, 0 oC-rt, 2 h; (d) TBDMSCl, imidazole, CH2Cl2, 4 h ; (e) Allylbromide, NaH, DMF, 0 oC-rt,  6 h; (f) (i) 
TBAF, THF, rt  (g) (COCl)2,DMSO,Et3N, CH2Cl2, -78 oC, 1 h.
General scheme for the preparation of aldehydes
5
ba c d
4
R
H
BocN
O
10
f g
11
R
OH
NHBoc
7
R
BocN
OHe
 
 
 
 
 
 
 
 
 
With aldehyde in hand, our next task was to perform Baylis-Hillman reaction, after trying 
the different conditions Better results were obtained (DABCO/sulpholane/rt) with ethyl 
acrylate. The rate of the reaction was faster and afforded the separable diastereomers (de 
54-70%) as products 12a-d and 12 a -d in good yields as well (Table 1). 
If the aldehydes have an electron-withdrawing group as N-substitution, the Baylis-
Hillman reaction was faster than when the absence of electron withdrawing group.31a 
Similarly, the stereoselectivity in the Baylis-Hillman reaction depends on the substitutions 
on the nitrogen atom in α-amino aldehydes.31b,c For example, if the amino aldehydes have 
N,N-disubstitution, the adduct formed was an anti stereoisomer (major), which can be 
explained on the basis of Felkin-Anh open chain model. 
 
 
 
 
 
 
 
 
 
 
 
CHO
BocN
CHO
BocN
CHO
BocN
CHO
BocN
Ph
Entry Aldehyde Time (h) Yield(%)
1
2
3
4
Table 1. A series of amino aldehyde derived Baylis-Hillman products.
12a:12a'
 (78:22)
Products
(anti/syn)
12c:12c'
 (82:18)
12b:12b'
 (85:15)
12d:12d'
 (77:23)
50
48
50
75
77
80
74
48
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On the contrary, the syn stereoselectivity is observed for the NH-Boc protected amino 
aldehydes. This phenomenon could be rationalized by invoking the proton bridged Cram’s 
cyclic model, due to the hydrogen bond between aldehyde and NH group.                                                            
Compound 12a was identified from the 1H NMR spectrum wherein the allylic proton 
appeared at δ 4.60 as broad doublet downfield in major isomer while the same proton 
appeared at  δ 4.42 as double doublet in its diastereomer 12a. 
  Our next task was the synthesis of substituted chiral tetrahydropyridines with RCM 
protocol. Among the commercially available ruthenium-based alkylidine Grubbs catalysts 8 
Grubbs’ second-generation catalyst is stable to air and moisture and useful in acidic 
environment, which was widely used for the synthesis of hindered substituted dienes, 
amino dienes and large size rings. 
The Baylis-Hillman adducts 12a-d and 12 a-d on cyclization independently with 
(0.1 eq) Grubbs’ second-generation catalyst in toluene at reflux conditions furnished 
products 13a-d and 13a-d respectively (Scheme 2, Table 2) without racemisation. By 
using this protocol we prepared C2-C3 substituted tetrahydropyridine-4-carboxylates as 
isoguvacine analogs. 
 
 
 
 
 
 
 
 
 
 
  Further, these compounds on exposure to catalytic dihydroxylation  with OsO4, 4-
methylmorphorine N-oxide as a co-oxidant
 
in acetone:water (4:1) furnished dihydroxylated 
products 14a-d and 14a-d (Table 3) respectively as single diastereomers interestingly with 
a tertiary  sterogenic center.  
R CHO
BOCN
R OEt
OH O
R OEt
OH O
BocNH
BocNH NBoc
R
HO
O
EtO
N
Boc
R
HO
O
EtO
N
Boc
R
HO
O
Et
O
OH
OH
N
Boc
R
HO
O
Et
O
OH
OH
13 a-d 14 a-d
13 a'−d' 14 a'-d'
11a: R = CH3
11b: R = (CH3)2CH
11c: R = (CH3CH2)CHCH3
11d: R = CH2Ph
Scheme 2. Reagents and conditions: (a) Ethyl acrylate(1.5 eq), DABCO (1 eq), sulpholane, rt; (b) G-II catalyst (0.1 eq), 
toluene, reflux,  (71-84%); (c) OsO4, NMMO (50% aq. sol.), acetone-water (4:1), 81-86%).
12a-d
12a'-d'
a
b
major  isomer
minor isomer
b c
c
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These substituted piperidinetriols are regarded as derivatives of their parent 
naturally occurring and synthetic azasugars (Figure 2 and 3). 
Next, the latent diversity points of one of the products, 13d was demonstrated 
(Scheme 3) by subjecting it to hydrogenation in presence of Pd-C at room temperature to 
give 13a and 13b in quantitative yields as a separable mixture. Both 13a and 13b form 
yet another class of interesting chiral piperidines as products. These chiral 
dihydropiperidine 13d (scheme 3) subjected to Michael addition reaction in the presence of 
CH3NO2, K2CO3, TBAF at room temperature in THF gives separable diastereomers 13c 
and 13d, and it is also converted to epoxide  (DBU, TBHP, DCE) gives the inseperable 
diastereomers 13e. This epoxide is ready to open with different nucleophiles creates the 
various libraries. 
 
 
 
 
 
 
 
 
 
 
  
 In conclusion, we have prepared a series of multifunctional adducts having α-
methylene-β-hydroxy-γ-amino acid structural motif by the Baylis-Hillman reaction of 
chiral N-Boc-α-amino aldehydes with ethyl acrylate in good yields and 
diastereoselectivities. In order to attain maximum diversity, these adducts on RCM reaction 
were converted into functionalized chiral tetrahydropyridines as potential analogs of 
isoguvacine; further the same compounds on cis-dihydroxylation resulted in stereo 
chemically high diverse azasugars.            
N
Boc
HO
O
EtO
N
Boc
HO
O
EtO
Ph
N
Boc
HO
O
EtO
Ph
No2
O
N
Boc
HO
O
EtO
No2
Scheme 3. reagents and conditions (a) H2, Pd-C, EtOAc, 5h,  (b) K2CO3, CH3NO2, TBAF, THF, 1 h. (c) DBU, TBHP, 
DCE, 5h.
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a
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Entry Baylis-Hillman
      Product
Time (h) Yield (%)
1
2
3
4
5
6
8
Table 2. A series of chiral tetrahydropyridines.
Tetrahydropyridines
13a
13'a
13b
13'b
13c
13'c
13d
13'd
7
20
18
18
22
22
24
24
83
80
81
82
82
79
84
84
22
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
N
Boc
CO2Et
HO
Ph
N
Boc
CO2Et
HO
Ph
 
 Entry Time (h) Yield(%)
1
2
3
4
5
6
8
Table 3. A series of azasugars
7
32
36
38
38
40
38
43
40
94
92
95
90
88
91
97
92
14a
14'a
14b
14'b
14c
14'c
14d
14'd
de (%)
>_99:1
Tetrahydropyridine Azasugars
>_99:1
>_99:1
>_99:1
>_99:1
>_99:1
>_99:1
>_99:1
N
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HO
EtO2C OH
OH
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HO
EtO2C OH
OH
N
Boc
HO
EtO2C OH
OH
N
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EtO2C OH
OH
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HO
EtO2C OH
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EtO2C OH
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Section B: Synthesis of 2-C-branched glycosides from diastereolective Baylis-
Hillman reaction  
This section dealt with the first use of sugar-derived α, β-unsaturated δ-lactone as chiral 
Michael acceptor in diastereolective Baylis-Hillman reaction  
The construction of C-C bonds is one of the most challenging tasks in the field of 
synthetic organic chemistry. Amongst the existing methods, the Baylis-Hillman reaction 
is recognized as an important C-C bond forming reaction that affords multifunctional 
products as versatile synthetic intermediates in organic synthesis. Equally important are 
C-branched sugars since they constitute part structures of many natural products besides 
being used as chiral synthons in the total synthesis of bioactive natural products. Hence, 
Baylis-Hillman adducts as C-branched sugars have both synthetic and biological 
significance. Though Baylis-Hillman reaction was reported with cyclic lactones 32 under 
Lewis acid mediated reaction conditions, its chiral version remained unexplored under 
similar conditions. An alternate strategy involving multi-step sequence was reported 
recently for the access of α,β-unsaturated lactone-derived adducts. The applicability of 
this protocol was limited because of lengthy sequences. However, to the best of our 
knowledge, excepting for a brief reference,33 the use of chiral lactone as a conventional 
Michael acceptor in Baylis-Hillman reaction has not been thoroughly investigated so far. 
As a part of our continued interest in Baylis-Hillman reaction34 and C-glycosides,28 
herein we report the first use of sugar-derived α, β-unsaturated δ-lactone as the chiral 
Michael acceptor in a DABCO catalyzed diastereoselective Baylis-Hillman reaction with 
several aromatic aldehydes to afford 2-C-branched glycosides as adducts (Equation 1).  
 
 
 
 
 
 
+
DABCO
anhyd. DMSO,  rt, 36 h
Yields 49-75%
3a-h
1a-h 2
Equation 1
O
AcO
OAc
O
O
AcO
OAc
O
R
HO
de's 30-82%
RCHO
*
H
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The readily accessible 4,6-diacetoxy-2,3-dideoxy-D-erythro-hex-2-enono-1,5-lactone 2 
was prepared from D-glucose by the modification of literature methods.35 Initially, 
Baylis-Hillman reaction between 2 and aryl aldehyde 1a was tried in several solvents like 
1,4-dioxane: water (1:1), CH2Cl2 and DMSO catalyzed by DABCO, TiCl4 and TiCl4-
TBAI. When 1,4-dioxane:water (1:1) was the solvent and DABCO the catalyst, acetate 
hydrolysis of 2 was a competing reaction. It is pertinent to mention that Lewis acid 
catalyzed Baylis-Hillman reaction (TiCl4 or TiCl4-TBAI/CH2Cl2/-78 °C) afforded 3a in 
low yields. Gratifyingly, when the same reaction was conducted in anhydrous DMSO and 
DABCO (50 mol%) as the lone catalyst with no additives at room temperature for 36 h 
furnished 3a (75% yield, de 82%) without any detectable side products.  
   Table1. Baylis-Hillman reaction of sugar-derived lactone 2 with several                   
arylaldehydes  catalyzed by DABCO in DMSO at room temperaturea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHO
NO2
CHOF
H
N CHO
O CHO
N
CHO
CHONC
Entry Aldehyde Productb Yield(%)c
1
2
3
4
5
6
7
de(%)d
70
82
76
40
3b
3a
3c
3d
3e
3f
3g 67
35
30
68
75
71
63
60
49
52
8
30
3h
60
1a
1b
1c
1d
1e
1f
1g
1h
a. All the reactions were conducted as described in the general experimental procedure in the 
reference section.
b.All the products were thoroughly characterized from their spectral data.
c. Isolated yields.
d.The ratio of isomers (de's) was determined based on the 1H NMR spectra.
(R)
CHOO2N
CHOCl
Cl
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Having established the reaction conditions, the versatility of the protocol was 
demonstrated with several aryl aldehydes. Consequently, reaction of 2 with aldehydes 1b-
h under similar conditions gave adducts 3b-h respectively (Table 1).  
All the products were thoroughly characterized by their spectral data. The diastereomeric 
ratio of adducts was established by the NMR analysis. For instance, 1H NMR of 3a 
displayed the lone olefinic proton at δ 6.94 as a doublet (J = 5.5 Hz) for the major isomer 
while the same proton appeared at δ 6.88 for the minor isomer with the integral ratio of 
91:9 (de 82%). The benzylic proton appeared at δ 5.62 as a doublet (J = 3.7 Hz) 
accounting for one proton and H-4 resonated at δ 5.52 as double doublet (J = 3.0, 6.79 
Hz) with the rest of the protons appearing at their expected chemical shifts. 
Correspondingly, 1H NMR of 3c displayed the olefinic proton at δ 6.54 as a doublet (J = 
6.33 Hz) for the major isomer while the same proton appeared at δ 6.30 for the minor 
isomer in a ratio of 88:12 (de 76%). The H-4 proton resonated at δ 5.53 and 5.26 for the 
major and minor isomers respectively in the same ratio. Similarly the de’s of all other 
adducts were calculated based on the relative integration of the separable protons. 
 
 
 
 
 
 
 
 
 
 
 
The observed distereoselectivity may be explained based on the fact that steric 
compulsions, zwitterionic stabilization and energy considerations play a crucial role in 
stereo differentiation during the aldol reaction (Scheme 1).  
Firstly it was conceived that the bulky DABCO adds onto the β-carbon of lactone, 
in a Michael fashion, from the least hindered β-face. Later, it may be considered that the 
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interaction of ‘Re’ face of aldehyde with ensuing enolate is sterically preferred due to less 
crowding and also result in a better-stabilized zwitterion if the aldehyde also approaches 
from the β-face of the lactone leading to cis disposition of substituents implying a ‘S’ 
configuration at the newly created center in the adduct (major isomer). Hence, the most 
favored zwitterionic intermediate (ZI-RR) is that wherein both the ‘oxy anion’ and 
DABCO ammonium ionoccupy the β-face of the sugar ring and are rightly poised for 
stabilization through an intramolecular hydrogen bonding. However, ZI-RS is less 
stabilized due to non-existence of these factors.  On the contrary, if the approach of the 
aldehyde is presumed to be from the α-face of the lactone, with DABCO ammonium ion 
already in place on the β-plane of the sugar-ring, though a Si-attack is feasible but the 
corresponding zwitterion would be less stabilized due to relatively more inter-atomic 
distances with the trans disposition of the substituents.  
The other possible conformations arising out of Michael addition of DABCO from the α-
side of the sugar ring though could be considered because the initial addition is 
inconsequential as DABCO subsequently eliminates to generate the double bond after the 
aldol reaction, were discounted based on the assumption that preferentially DABCO 
Michael addition occurs from the least hindered side i.e. β face of the lactone. 
In order to rationalize the above assumptions, it is intended to explain the lactone induced 
diastereoselectivity of the Baylis-Hillman adducts with the help of computational studies 
with energy transition states and zwitterion stabilities of all the possible conformers to 
establishing the absolute configuration of the major adduct. For all the substitutents the 
energy barrier for the formation of RR is intermediate is lower compared to that to the 
formation of RS isomers most of the cases.  
Thus, the computational studies validates the experimental observation that the preferred 
configuration at the stereogenic center of the products is S.  
In conclusion, diastereoselective Baylis-Hillman reaction using sugar-derived α, 
β-unsaturated δ-lactone as the Michael acceptor with several aryl aldehydes to afford 
adducts in moderate to good yields with de’s 30-82% (major isomer ‘S’) under mild 
reaction conditions was demonstrated for the first time.  
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